Pantoprazol Aurovitas (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Aurovitas, is a Proton‑Pump Inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Pantoprazol Aurovitas is a proton‑pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive gastritis and duodenal ulcers: accelerates healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder.

Pantoprazol Aurovitas may cause a range of adverse reactions. Most are mild and resolve after treatment cessation.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Acute interstitial nephritis: changes in urine output, flank pain. - Fracture risk with long‑term use: hip, wrist or spine fractures. - Vitamin B12 deficiency with prolonged therapy.

Before initiating therapy, consider the following precautions: - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for reduced efficacy of drugs that need an acidic environment. - Monitor for osteoporosis: long‑term use may affect bone mineral density. - Evaluate pregnancy and lactation status: use only if clearly needed. - Observe for signs of infection: especially Clostridioides difficile. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole can affect the absorption and metabolism of several medicines. Interaction severity varies, so monitoring is essential.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption and loss of efficacy. - HIV protease inhibitors (ritonavir, atazanavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Antiplatelet drug clopidogrel: diminished antiplatelet effect. - Warfarin: potential increase in INR values. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: possible increase in serum concentration. - Oral contraceptives: slight reduction in hormonal efficacy.